Agenus Inc (AGEN)
10.22
-0.56
(-5.19%)
USD |
NASDAQ |
May 16, 10:48
Agenus Shareholders Equity (Quarterly): -201.43M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -201.43M |
December 31, 2023 | -160.33M |
September 30, 2023 | -129.11M |
June 30, 2023 | -93.20M |
March 31, 2023 | -58.54M |
December 31, 2022 | -61.28M |
September 30, 2022 | -20.38M |
June 30, 2022 | 3.416M |
March 31, 2022 | 15.72M |
December 31, 2021 | 34.44M |
September 30, 2021 | 41.85M |
June 30, 2021 | -247.12M |
March 31, 2021 | -189.66M |
December 31, 2020 | -203.67M |
September 30, 2020 | -198.49M |
June 30, 2020 | -218.62M |
March 31, 2020 | -195.92M |
December 31, 2019 | -225.36M |
September 30, 2019 | -199.69M |
June 30, 2019 | -157.23M |
March 31, 2019 | -116.13M |
December 31, 2018 | -172.47M |
September 30, 2018 | -130.41M |
June 30, 2018 | -112.71M |
March 31, 2018 | -113.39M |
Date | Value |
---|---|
December 31, 2017 | -75.82M |
September 30, 2017 | -51.59M |
June 30, 2017 | -17.48M |
March 31, 2017 | 8.905M |
December 31, 2016 | -39.13M |
September 30, 2016 | -21.04M |
June 30, 2016 | 16.88M |
March 31, 2016 | 44.45M |
December 31, 2015 | 70.73M |
September 30, 2015 | 76.98M |
June 30, 2015 | 87.19M |
March 31, 2015 | 46.26M |
December 31, 2014 | 23.02M |
September 30, 2014 | 48.87M |
June 30, 2014 | 57.63M |
March 31, 2014 | 63.29M |
December 31, 2013 | -4.481M |
September 30, 2013 | -2.877M |
June 30, 2013 | -17.26M |
March 31, 2013 | -28.26M |
December 31, 2012 | -23.18M |
September 30, 2012 | -18.74M |
June 30, 2012 | -16.94M |
March 31, 2012 | -16.21M |
December 31, 2011 | -26.41M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-247.12M
Minimum
Jun 2021
41.85M
Maximum
Sep 2021
-123.23M
Average
-158.78M
Median
Shareholders Equity (Quarterly) Benchmarks
Ligand Pharmaceuticals Inc | 806.52M |
Protalix BioTherapeutics Inc | 29.79M |
InfuSystems Holdings Inc | 52.28M |
PAVmed Inc | -53.83M |
Allogene Therapeutics Inc | 461.37M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 256.56M |
Total Liabilities (Quarterly) | 446.88M |
Debt to Equity Ratio | -0.0674 |
Current Ratio | 0.2357 |
Net Debt Paydown Yield | -0.03% |